Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trial Imaging Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
... the Clinical Trial Imaging market including the COVID-19 pandemic implications for Clinical Trial Imagings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, ... Read More
-
Clinical Trials Management System Market: Current Analysis and Forecast (2022-2030)
... tracking of patient enrolment, scheduling, and visits, as well as the monitoring of study progress and the collection, management, and analysis of trial data. CTMS also helps ensure compliance with regulatory requirements and guidelines, including ... Read More
-
Myelodysplastic Syndrome - Pipeline Insight, 2023
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of MI in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for MI. The marketed drugs space for MI consists of mostly small molecules that are 3 hydroxy 3 methylglutaryl coenzyme ... Read More
-
Global Clinical Trials Market Report and Forecast 2023-2031
... CAGR of 5.40% during the forecast period of 2023-2031 to attain a value of nearly USD 75 billion by 2031. Clinical Trial Market: Introduction Clinical trials are research studies involving human participants, designed to evaluate ... Read More
-
Clinical Trial Imaging Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such As Increasing Demand for More Precise ... Read More
-
Clinical Trial Imaging Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such As Increasing Demand for More Precise ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. No approved marketed drugs are currently available for the treatment of BDD. R&D activity within the BDD space is ... Read More
-
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... (Hurler Syndrome ) - Global Clinical Trials Review, 2023 provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Inflammatory Bowel Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. Report includes an overview of trial numbers and ... Read More
-
Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating to the clinical trials on Duchenne Muscular Dystrophy. Report includes an overview of trial numbers and ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Amyotrophic Lateral Sclerosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyotrophic Lateral Sclerosis. Report includes an overview of trial numbers and ... Read More
-
Paediatric Clinical Trials Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. High Costs Related to Clinical Studies Likely to ... Read More
-
Paediatric Clinical Trials Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. High Costs Related to Clinical Studies Likely to ... Read More
-
Ankylosing Spondylitis (Bekhterev's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trials Review, 2023 provides an overview of Ankylosing Spondylitis (Bekhterev's Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Ankylosing Spondylitis (Bekhterev's Disease). Report includes an overview ... Read More
-
Spondyloarthritis (Spondyloarthropathy) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... provides an overview of Spondyloarthritis (Spondyloarthropathy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Spondyloarthritis (Spondyloarthropathy). Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in ... Read More
-
Graft Versus Host Disease (GVHD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... - Global Clinical Trials Review, 2023 provides an overview of Graft Versus Host Disease (GVHD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Graft Versus Host Disease (GVHD). ... Read More
-
Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trials Review, 2023 provides an overview of Diffuse Large B-Cell Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview ... Read More
-
Preclinical CRO Market Forecast till 2030
... therapies increases, pharmaceutical and biotech companies are allocating larger budgets for R&D to accelerate the drug development process. This includes outsourcing preclinical research activities to CROs, which offer specialized services and expertise in conducting preclinical ... Read More
-
IgA Nephropathy (Berger's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trials Review, 2023 provides an overview of IgA Nephropathy (Berger's Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on IgA Nephropathy (Berger's Disease). Report includes an overview ... Read More
-
Clinical Trials Market - By Phases (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Study, Observational Study, Expanded Access Study), By Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology) & Forecast, 2023 - 2032
... & Forecast, 2023 - 2032 Global Clinical Trials Market size is anticipated to record an appreciable valuation by 2032, owing to the increasing prospects for performing clinical trials in the Asia Pacific. The consistent rise ... Read More
-
Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 1 billion prevalent cases of AC in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for AC. The innovator marketed drugs space for AC mainly consists of dual-acting antihistamines and mast cell inhibitors. ... Read More
-
Membranous Nephropathy
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 0.49 million diagnosed prevalent cases of IPF in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for IPF. Currently, there are two leading marketed drugs for the treatment of IPF, with Roche ... Read More
Research Assistance
